Ginkgo Bioworks Holdings (DNA) Cash from Discontinued Operations (2025 - 2026)
Ginkgo Bioworks Holdings (DNA) reported Cash from Discontinued Operations of 253000.0 for Q1 2026, up 97.12% on a YoY basis from 128350.93 in Q1 2025, and up 97.12% quarter-over-quarter from 8772000.0 in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Cash from Discontinued Operations (2025 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings has reported Cash from Discontinued Operations for 2 years, with the latest figure at 253000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -59.14 Mn |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn | -253,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -253,000.00 |
| Mar 31, 2026 | -253,000.00 |
| Mar 31, 2025 | -8.77 Mn |
| Mar 31, 2025 | -8.77 Mn |